Brompheniramine Maleate

   
Google
 
Web NewDrugInformation.com

Brompheniramine Maleate


Drug - Brompheniramine Maleate
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Brompheniramine Maleate
Multiple ingredients are in alphabetical order.

Strength - 4MG
The potency of the active ingredient(s), Brompheniramine Maleate. May repeat for multiple part products.

Applicant - PIONEER PHARMS
The firm name holding legal responsibility for Brompheniramine Maleate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088604
The FDA assigned number to Brompheniramine Maleate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Brompheniramine Maleate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 13, 1984
The date Brompheniramine Maleate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Brompheniramine Maleate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Brompheniramine Maleate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pioneer Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Brompheniramine Maleate.

Brompheniramine Maleate